These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Chagas disease]. Develoux M; Lescure FX; Le Loup G; Pialoux G Rev Med Interne; 2009 Aug; 30(8):686-95. PubMed ID: 19201068 [TBL] [Abstract][Full Text] [Related]
27. Drug Discovery for Paediatric Chagas Disease. Thota S; Morel CM Mini Rev Med Chem; 2018; 18(9):776-780. PubMed ID: 26202205 [TBL] [Abstract][Full Text] [Related]
28. Immunosuppression and Chagas disease: a management challenge. Pinazo MJ; Espinosa G; Cortes-Lletget C; Posada Ede J; Aldasoro E; Oliveira I; Muñoz J; Gállego M; Gascon J PLoS Negl Trop Dis; 2013; 7(1):e1965. PubMed ID: 23349998 [TBL] [Abstract][Full Text] [Related]
29. The Epidemiology, Clinical Manifestations, and Management of Chagas Heart Disease. Malik LH; Singh GD; Amsterdam EA Clin Cardiol; 2015 Sep; 38(9):565-9. PubMed ID: 25993972 [TBL] [Abstract][Full Text] [Related]
30. Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection. Barbosa JMC; Pedra Rezende Y; de Melo TG; de Oliveira G; Cascabulho CM; Pereira ENGDS; Daliry A; Salem KS Microbiol Spectr; 2022 Feb; 10(1):e0185221. PubMed ID: 35138142 [TBL] [Abstract][Full Text] [Related]
31. Assessing the effectiveness of Chagas disease education for healthcare providers in the United States. Stigler Granados P; Pacheco GJ; Núñez Patlán E; Betancourt J; Fulton L BMC Infect Dis; 2020 Oct; 20(1):743. PubMed ID: 33036559 [TBL] [Abstract][Full Text] [Related]
32. Current status of Chagas disease chemotherapy. Guedes PM; Silva GK; Gutierrez FR; Silva JS Expert Rev Anti Infect Ther; 2011 May; 9(5):609-20. PubMed ID: 21609270 [TBL] [Abstract][Full Text] [Related]
33. Updated Estimates and Mapping for Prevalence of Chagas Disease among Adults, United States. Irish A; Whitman JD; Clark EH; Marcus R; Bern C Emerg Infect Dis; 2022 Jul; 28(7):1313-1320. PubMed ID: 35731040 [TBL] [Abstract][Full Text] [Related]
35. Cytokine responses in Trypanosoma cruzi-infected children in Paraguay. Samudio M; Montenegro-James S; Cabral M; Martinez J; Rojas de Arias A; James MA Am J Trop Med Hyg; 1998 Jan; 58(1):119-21. PubMed ID: 9452302 [TBL] [Abstract][Full Text] [Related]
36. Chagas Disease: Chronic Chagas Cardiomyopathy. Echavarría NG; Echeverría LE; Stewart M; Gallego C; Saldarriaga C Curr Probl Cardiol; 2021 Mar; 46(3):100507. PubMed ID: 31983471 [TBL] [Abstract][Full Text] [Related]
37. Access to Chagas disease treatment in the United States after the regulatory approval of benznidazole. Yoshioka K; Manne-Goehler J; Maguire JH; Reich MR PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008398. PubMed ID: 32569280 [TBL] [Abstract][Full Text] [Related]
39. Mother-to-child transmission of Trypanosoma cruzi infection (Chagas disease): a neglected problem. Norman FF; López-Vélez R Trans R Soc Trop Med Hyg; 2014 Jul; 108(7):388-90. PubMed ID: 24771504 [TBL] [Abstract][Full Text] [Related]
40. Estimating the Burden of Chagas Disease in the United States. Manne-Goehler J; Umeh CA; Montgomery SP; Wirtz VJ PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005033. PubMed ID: 27820837 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]